Applying Liver MPS Technologies to Improve Preclinical DILI Prediction
- Demonstrate how liver microphysiological systems improve mechanistic understanding and human relevance in assessing drug‑induced liver injury
- Present case studies where liver MPS provide earlier or more predictive detection of hepatotoxic liabilities compared with traditional in vitro assays
- Highlight translational biomarkers and functional readouts from MPS that strengthen decision‑making in preclinical safety assessment